Fraser, Ilanca

Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa. [electronic resource] - PharmacoEconomics Apr 2016 - 403-17 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1179-2027

10.1007/s40273-015-0356-x doi


Antiviral Agents--economics
Benzimidazoles--economics
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination--economics
Fluorenes--economics
Genotype
Hepacivirus--genetics
Hepatitis C, Chronic--drug therapy
Interferon-alpha--economics
Markov Chains
Models, Statistical
Polyethylene Glycols--economics
Quality-Adjusted Life Years
Recombinant Proteins--economics
Ribavirin--economics
Sofosbuvir
South Africa
Uridine Monophosphate--analogs & derivatives